Therapeutic agents comprising an antiangiogenic agent in combination with an Src-inhibitor and their therapeutic use

Details for Australian Patent Application No. 2004237132 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen Robert; Curwen, Jon Owen

Agent Davies Collison Cave

Pub. Number AU-B-2004237132

PCT Pub. Number WO2004/098604

Priority 0310401.5 07.05.03 GB

Filing date 4 May 2004

Wipo publication date 18 November 2004

Acceptance publication date 18 October 2007

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/098604 Priority application(s): WO2004/098604

18 October 2007 Application Accepted

  Published as AU-B-2004237132

14 February 2008 Standard Patent Sealed

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237134-Sterilisation device

2004237131-Particulate materials